Your trusted source for investing success
By Jocelyn Aspa
Infinity Pharmaceuticals, Sorrento Therapeutics, CASI Pharmaceuticals, KalVista Pharmaceuticals, and Prima BioMed topped last week’s NASDAQ biotech stock list.
In the cleanest form Biotechnology refers to the sector that through cellular and biomolecular methods to improve or create products in various industries.
The world’s pharmaceutical industry is dominated by the American and European markets. According to Forbes top companies of 2017, the 10 biggest drug companies are all located in these two regions.
Pharmaceutical companies work towards achieving the goal of bringing new cures or treatments to the market and improve the treatment available for patients.
Zogenix, Aradigm, Vermillion, Aralez Pharmaceuticals and Kura Oncology top the NASDAQ biotech stock list.
CASI Pharmaceuticals, Savara, Adverum Biotechnologies, ChromaDex Therapeutics and MannKind top the NASDAQ biotech stock list.
For those looking to avoid volatility, these biotechnology ETFs may be the ticket.
Major players in the pharmaceutical industry include Johnson & Johnson, Novartis, Roche, Pfizer and Merck.
Critical Outcome Technologies announced their president and CEO Alison Silva will co-chair the Global Genes RARE Partnering & Investor Forum.
Neovasc, Adaptimmune, Curis, Vericel and MannKind top the NASDAQ biotech stock list.
VIVUS announced it entered into a settlement agreement with Dr. Reddy’s Laboratories related to the patent litigation of Qsymia capsules CIV.
Insys Therapeutics has settled a suit with the state of Illinois, in which the company will have to pay $4.5 million due to their marketing and selling tactics of their fentanyl-based treatment Subsys.
Delcath Systems, MannKind, Zogenix, BioLife Solutions and BioDelivery Sciences top the NASDAQ biotech stock list.
By Jocelyn Aspa
The companies will collaborate to study and develop blockchain and artificial intelligence solutions for healthcare data.
Reports have indicated to the growth for the industry based on the curiosity and need for patients to find new therapies involved to their diseases.
Pieris Pharmaceuticals announced the appointment of a new senior vice president and chief financial officer.
Cogentix Medical, Molecular Templates, Celldex Therapeutics, Cerus and Kura Oncology top the NASDAQ biotech stock list.
On his first three months as commissioner of the Food and Drug Administration, Scott Gottlieb has already taken significant steps to spark competition in the pharmaceutical space and help bring down the costs of some vital products.
As part of a wide attempt to decrease the impact of opioid abuse, a healthcare company’s novel treatment of alcohol and opioids addiction will be used in three EnLite Clinics in Ohio.
Novavax, Agenus, Sierra Oncology, Durect and Cogentix top the NASDAQ biotech stock list.
